Somerset Group’s AbbVie ABBV Stock Holding History

Somerset Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Hold	6,803	–	–	1.05%	31
2025 Q4	$1.59M	Hold	6,803	–	–	1.2%	27
2025 Q3	$1.58M	Hold	6,803	–	–	1.25%	27
2025 Q2	$1.26M	Hold	6,803	–	–	1.07%	29
2025 Q1	$1.43M	Hold	6,803	–	–	1.3%	25
2024 Q4	$1.21M	Hold	6,803	–	–	1.1%	26
2024 Q3	$1.34M	Hold	6,803	–	–	1.24%	26
2024 Q2	$1.17M	Hold	6,803	–	–	1.04%	27
2024 Q1	$1.24M	Sell	6,803 -600	-8%	-$103K	1.16%	26
2023 Q4	$1.15M	Hold	7,403	–	–	0.96%	30
2023 Q3	$1.1M	Sell	7,403 -771	-9%	-$113K	1.04%	29
2023 Q2	$1.1M	Sell	8,174 -35	-0.4%	-$5.13K	0.92%	31
2023 Q1	$1.31M	Buy	8,209 +20	+0.2%	+$3.06K	1.14%	27
2022 Q4	$1.32M	Sell	8,189 -700	-8%	-$107K	1.17%	26
2022 Q3	$1.19M	Hold	8,889	–	–	1.09%	25
2022 Q2	$1.36M	Sell	8,889 -22	-0.2%	-$3.36K	1.18%	25
2022 Q1	$1.45M	Hold	8,911	–	–	1.04%	26
2021 Q4	$1.21M	Hold	8,911	–	–	0.81%	32
2021 Q3	$961K	Sell	8,911 -400	-4%	-$45.7K	0.69%	33
2021 Q2	$1.05M	Buy	9,311 +58	+0.6%	+$6.53K	0.75%	34
2021 Q1	$1M	Sell	9,253 -200	-2%	-$21.4K	0.76%	33
2020 Q4	$1.01M	Buy	9,453 +52	+0.6%	+$5K	0.81%	31
2020 Q3	$823K	Buy	+9,401	New	+$885K	0.75%	31

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Somerset Group's ABBV Position: Q1 2026 in Review

Somerset Group held its AbbVie (ABBV) position steady in Q1 2026 at 6,803 shares worth $1.42M. The position accounts for 1.05% of the portfolio, ranked #31.

Somerset Group first reported a position in ABBV in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.59M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Somerset Group held 6,803 shares of AbbVie worth $1.42M as of Q1 2026.
Somerset Group left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 1.05% of Somerset Group's portfolio in Q1 2026, its #31 holding.
Somerset Group first reported a position in AbbVie in Q3 2020 and has held it in 23 quarters since.
Somerset Group's AbbVie position peaked at $1.59M in Q4 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Somerset Group's 13F filing for Q1 2026, filed 13 May 2026.